SlideShare a Scribd company logo
1 of 20
CompoundCompound
ClassClass
SetSet # substances# substances Drug discovery algorithmDrug discovery algorithm
1. NCI #1 #1 16 Compounds screened with ‘Auto
dock 4’
Ranked
Verified with so-called
‘relaxed complex scheme’
2. FDA #2 1 in house (sigma)
11 more predicted but
financially prohibitive
1 pending (Dec 2009)
3. NCI #2 #3 8 Identified using a fragment
based approach:
 Initially docked small fragments
into REL 1
 Identified favourable fragments
 Linked together and several
databases screened
4. Hit 2 lead #3 15
5. Sigma #3 2
Identify compounds that bind to ATP binding pocket of REL 1, viz. :Identify compounds that bind to ATP binding pocket of REL 1, viz. :
1 Strong lead !1 Strong lead !
3 Strong leads !3 Strong leads !
2 Nominal_100uM2 Nominal_100uM
Also,Tetracycline needs to be evaluatedAlso,Tetracycline needs to be evaluated
CompoundCompound
TypeType
CompoundCompound 1010µµMM 100100µMµM TitratedTitrated N=N= ICIC5050 RangeRange CommentsComments
NCI BatchNCI Batch
#2#2
# 45609 ! 95 %
(78%)
(88%) 33 3-1uM  Discrepancy between
assays above predicted
IC50 range
 Repeat ?
Discrepancy between
assays
Repeated ! (#0036)
# 162535 !!# 162535 !! 85_90 %
(85%)
(~98%)*
(90 %)
(>99.9%)*
>3>3
(+2)(+2)
~1uM (N=1)
~3-1uM (N=3)
# 1698 ! 80 %
(50%)
(90%) 33
(+2)(+2)
10uM- 3uM (N=2)
3-1uM (N=1)
NCI BatchNCI Batch
#1#1
# 117079 30_80% >99%
(~80 %)
(~50-70%)
>3>3 100uM- 30uM
(N=4)
 30uM (N=1)
Discrepancy between
assays
above IC50 range
 Furthermore, IC50’s differ
between assays
 Repeat ?
# 125908 20_70% ~95 %
(~50-70%)
>3>3 100uM- 30uM
(N=3)
 ~30uM (N=1)
# 45201 NA ~70% Yet to do !!Yet to do !!
Sigma rareSigma rare
LibraryLibrary
MordantMordant
Black !!Black !!
(~98%)* (~99.8%)* >3>3 ~1uM Completed
 Values derive from titrations’
 Identified using fragment based algorithm
 Identified using Auto Dock 4 relaxed complex
scheme
Assay #0036 is an attempt to clarify IC50’s for
# 1698 & #162535
Regarding # 45609 IC50’s concur but values differ
above this threshold
Regarding #117079 & #125908 some assays have
different IC50’s
Furthermore, those with similar values differ above
IC50 titrant
* Values derived from 0.25ul undiluted prep #1
34B
MBMB
#162535#162535
# 45609# 45609
# 1698# 1698
1uM1uM
>/=1uM>/=1uM
3-1uM3-1uM
>3uM>3uM
% (Putative) Inhibition of REL 1 Ligation (Adenylation) by Mordant Black (solute) relative to DMSO
(solvent)_# Mordant Black Molarity Titration
100uM
100uM
30uM
30uM
10uM
10uM
DMSO
DMSO
3uM
3uM
1uM
1uM
300nM
300nM
100nM
100nM
30nM
30nM
0
20
40
60
80
100
120
140
Prep #3_050203 Prep #1_080802
Mordant Black Molarity Titration: 100uM-30nM
SpecificSignal/DMSO_%
3.4%3.4%
10%10%
23.7%23.7%
52%52%
81%81%
<0.5%<0.5% 5%5%
26.5%26.5%
55.8%55.8%
75%75%
1ul Enzyme1ul Enzyme 0.25ul Enzyme0.25ul Enzyme
Although both REL 1 BAC preps differ with regard to
intrinsic activity both yield putative IC50’s approx to
1uM
This concurs with prior assays100uM100uM 30nM30nM
50S50S-1-1
100S100S-1-1
% (Putative) Inhibition of Ligation (Adenylation) by Mordant Black (solute) relative to DMSO
(solvent)_# Mordant Black Molarity Titration
30uM
30uM
10uM
10uM
10uM
100uM
100uM
100uM
30uM
0
20
40
60
80
100
120
140
Prep #3_050203 Prep #1_080802 Prep #1_080802
Mordant Black Molarity Titration: 100uM-30nM
SpecificSignal/DMSO_%
# 0029A # 0033A
28,500,000 152,500,000 203,500,000
52%
56% 54%
1ul 50% REL 1 0.25ul 50% REL 1 1ul undiluted REL 1
17 HR17 HR 1 HR !
For assays depicted (N=3) IC50 consistently approximates to ~1uM
Undiluted prep #1 displays massively greater signal than either glycerol diluted #1 or #3
% (Putative) Inhibition of Ligation (Adenylation) by Mordant Black (solute) relative to DMSO
(solvent)_# Mordant Black Molarity Titration
DMSO
DMSO
100uM
100uM
30uM
30uM
10uM
10uM
3uM
3uM
1uM
1uM
300nM
300nM
100nM
100nM
30nM
30nM
0
20
40
60
80
100
120
140
Prep #1_080802 Prep #3_050203
Molarity Titration: 100uM-30nM
SpecificSignal/DMSO_%
24+/-5.6%
59+/-5.2%
24%
52%
IC50 approximates
to 1uM for N=5
Combining data from assays #0029_33_34 culminates in predicted IC50 of ~1uM (N=4)
In terms of IC50 alone this is consistent with data from REL 1 prep #3 also derived from #0029
% (Putative) Inhibition of Ligation (Adenylation) by #162535 (solute) relative to DMSO (solvent)_#
162535 Molarity Titration
DMSO
DMSO
DMSO
3uM
3uM
3uM
1uM
1uM
1uM
0
20
40
60
80
100
120
140
160
180
# 0018A # 0033B # 0034B
Molarity Titration: 100uM-30nM
MeanSpecificsignal/DMSO_%
DMSO
100uM
30uM
10uM
3uM
1uM
300nM
100nM
30nM
# 162535
1ul Undiluted Prep #1_080802 0.25ul Undiluted Prep #1_0808020.5ul 50% Glycerol diluted prep
36%
67%
42%
90%
12%
48%
25,000,000 217,000,000 45,000,000
For N=3 predicted IC50 approximates to ~ 2uM
For N=1 predicted IC50 ~1uM (1ul undiluted prep #1)
Therefore repeated using 0.25ul undiluted prep #1
Thus, now N=4 for 0.25ul undiluted prep #1
Repeated !Repeated !
Variable background was a
confounding factor when it came
to signal comparison for the
different titrants
Nevertheless, evident IC50 was
approximately 1uM
This concurs with assays #34
& #35
% (Putative) Inhibition of Ligation (Adenylation) by #1698 (solute) relative to DMSO (solvent)_#
1698 Molarity Titration
DMSO
DMSO
100uM
100uM
30uM
30uM
10uM
10uM
3uM
3uM
1uM
1uM
300nM
300nM
100nM
100nM
30nM
30nM
0
20
40
60
80
100
120
# 0018B # 0035A
MeanSpecificSignal/DMSO_%
IC50 resides here
# 1698
28, 000,000 190, 000,000
27%
53%
38%
61%
For N=1 predicted IC50 approximates to 10uM
For N=2 predicted IC50 lies somewhere between 10uM & 3uM
#0035A = 0.25ul undiluted prep #1_080802
Therefore repeated using (similarly) 0.25ul undiluted prep #1
Thus, for 0.25ul undiluted prep #1, now N=4 !
Repeated !Repeated !
108, 000, 000 counts108, 000, 000 counts
153, 000, 000 counts153, 000, 000 counts
% (Putative) Inhibition of Ligation (Adenylation) by #45609 (solute) relative to DMSO
(solvent)_# 45609 Molarity Titration
DMSO
DMSO
100uM
100uM 30uM30uM
10uM
10uM
3uM
3uM
1uM
1uM
300nM
300nM
100nM
100nM
30nM
30nM
0
20
40
60
80
100
120
140
# 0035B # 0016B
Molar Titration
MeanSpecificSignal_%DMSO
IC50 resides here
199,000,000 counts ! 10,000,000 counts !
0.9%
1.6%
7.9%
36%
68%
IC50 resides here
12%
16%
22%
38%
74%
Thus, for N=3 predicted of IC50 ~3-1uM
However, above this threshold, titrants for respective assays differ considerably with respect to putative
inhibition
 Assay #0016B = 0.5ul 50 % glycerol diluted prep
 Assay #0035B = 0.25ul undiluted prep #1_080802
Repeat ??Repeat ??
% (Putative) Inhibition of REL 1 Ligation (Adenylation) by #117079 (solute) relative to DMSO
(solvent)_# 117079 Molarity Titration
DMSO
DMSO
100uM
100uM
30uM
30uM
10uM
10uM
3uM
3uM
1uM
1uM
300nM
300nM
100nM
100nM
30nM
30nM
0.0
20.0
40.0
60.0
80.0
100.0
120.0
140.0
BAC Prep #3_050203 BAC Prep #1_080802
#117079 Molarity Titration: 100uM-30nM
SpecificSignal/DMSO_%
18.6%18.6%
54%54%
23.4%23.4%
75.6%75.6%
1ul Enzyme1ul Enzyme 0.25ul Enzyme0.25ul Enzyme
Predicted IC50 Prep #3 ~30uM
Predicted IC50 for prep #100uM-30uM
The latter concurs with previous assays50S50S-1-1
100S100S-1-1
IC50 resides somewhere
between 100uM & 30uM
In the main, this concurs
with previous assays, i.e.:
 #0011 & #0012
 #0029B_Prep #1_080802
However, predicted IC50
for #29B_prep #3 approx.
to 30uM rather than 100uM
To illustrate discrepancies
further:
 Putative inhibition @100uM
for assays #0011 & #0012
>99%
 For assay #0029B ~ 80%
 For assay #0032A/B ~ 50
-70%
# 117079 Molarity Titration: 1mM-1uM# 117079 Molarity Titration: 1mM-1uM
10S10S-1-1
10-20S10-20S-1-132A
32B5S5S-1-1 10S10S-1-1
1ul Prep #31ul Prep #3
% (Putative) Inhibition of REL 1 Ligation (Adenylation) by #125908 (solute) relative to DMSO (solvent): # 125908
Molarity Titration. Assay #0031A
1mM 1mM
DMSO
DMSO
300uM
100uM
100uM
30uM
30uM
10uM
10uM
3uM
3uM
1uM
1uM
0
20
40
60
80
100
120
140
# 31A_1 # 31A_2
Molarity Titration: 1mM-1uM
SpecificSignal/DMSO_%
32.5%
77.7%
17.4%
48.4%
86.4%
IC50 resides
here
IC50 resides
here
% (Putative) Inhibition of REL 1 Ligation (Adenylation) by #125908 (solute) relative to DMSO (solvent): # 125908
Molarity Titration. Assay #0031B
DMSO
DMSO
1mM1mM
300uM
300uM
100uM
100uM
30uM
30uM
10uM
10uM
3uM
3uM
1uM
1uM
0
20
40
60
80
100
120
140
# 31B_1 # 31B_2
Molarity Titration: 1mM-1uM
SpecificSignal/DMSO_%
17.4%
35.5%
60.9%
13.4%
30.2%
51.4%
IC50 resides here IC50 resides here
Predicted IC50 ~30uM: N=1
Predicted IC50 100uM-30uM: N=3
The latter concurs with previous assays
% (Putative) Inhibition of REL 1 Ligation (Adenylation) by #117079 (solute) relative to DMSO (solvent):
#117079 Molarity Titration. Assay #0032A/B
DMSO
1m M 300uM
100uM
30uM
10uM
3uM
1uM
0
20
40
60
80
100
120
N = 3
Molarity Titration #117079: 1mM - 1uM
MeanSpecificSignal/DMSO_%
DMSO
1mM
300uM
100uM
30uM
10uM
3uM
1uM
Plan of action:Plan of action:
1. Either combine this data with #0029B_prep #1 (N=4)
2. Or repeat assay 0.25ul undiluted prep #1_080809
=10=10µMµM
=100=100µMµM
Low S:N precluded quantitation !
This was even true of depicted assay #0026, wherein cassette left for 6 days !
BAC 1 prep with low intrinsic activity (also common to H2L compounds)
 Green = 1ul 50% Prep #3_050203 + 0.1% Triton X-100
 Black = 1ul undiluted prep #1_080802
 Blue = 1ul undiluted prep #1_080802
 Green = 0.25ul undiluted prep #1_080802
200S200S-1-1
1000S1000S-1-133A
33B100S100S-1-1
1000S1000S-1-1
Loss of Specific Signal (DMSO) with Freeze thawing: REL1 'prep #3_050203' vs 'Prep #1_080802'
#0031
#0032
#0027
#0027
#0029
#0029
#0034
#0035
#0036
0.00E+00
5.00E+07
1.00E+08
1.50E+08
2.00E+08
2.50E+08
DMSO_#1_0.25ul DMSO_#3_0.25_1ul
Assays
SpecificSignal
#0027
#0029
#0031
#0032
#0034
#0035
#0036
0.25ul undiluted Prep #3_050203
0.25ul Prep #1_080802
1ul 50 % Prep #3_050203
SummarySummary
1. Mordant black has evident IC50 approximating to 1uM (N=5): Best lead !!
2. Regarding #45609, assays alight on IC50 approximating to 3-1uM (N=3) but differ
with respect to putative titrant inhibition above that threshold; Repeat ?
3. With reference to #162535 & #1698, discrepancies evident between assay
predicted IC50 values and for #1698 in particular N<3 for alternative values; There
fore repeated (#0036)
4. Regarding #117079 & #125908, some assays display putative different IC50’s but
an N>/=3 exists for one value
5. However, titrant values above the predicted IC50 thresholds also differ: Repeat ?
In general, same enzyme batches concur more often and undiluted prep
#1_080802 has yielded highest signal to noise
Thus, in general and N>/= 3 derived from this REL 1 batch would constitute
the ideal
Future WorkFuture Work
1. Quantify #0036
2. Repeat other assays described to nullify IC50 and preferably titrant differences in
general, with a bias towards N>/= 3 from the same enzyme batch
3. Submit putative inhibitory values to Graph Pad Prism© to compute exact IC50s’
4. Complete titrations for #45201

More Related Content

What's hot

Triphenylmethane and derivatives
Triphenylmethane and derivativesTriphenylmethane and derivatives
Triphenylmethane and derivativesDheeraj Saini
 
DƯỢC LÝ HỌC LÂM SÀNG NHI KHOA
DƯỢC LÝ HỌC LÂM SÀNG NHI KHOADƯỢC LÝ HỌC LÂM SÀNG NHI KHOA
DƯỢC LÝ HỌC LÂM SÀNG NHI KHOASoM
 
DƯỢC LÝ HỌC LÂM SÀNG NHI KHOA
DƯỢC LÝ HỌC LÂM SÀNG NHI KHOADƯỢC LÝ HỌC LÂM SÀNG NHI KHOA
DƯỢC LÝ HỌC LÂM SÀNG NHI KHOASoM
 
M3MP=MMP TDS
M3MP=MMP TDSM3MP=MMP TDS
M3MP=MMP TDSSherry T.
 
B&S Group Fluorescent Dyes
B&S Group Fluorescent DyesB&S Group Fluorescent Dyes
B&S Group Fluorescent Dyesbsgroup
 
Catalogue for B&S Fluorescent Dyes 2013
Catalogue for B&S Fluorescent Dyes 2013Catalogue for B&S Fluorescent Dyes 2013
Catalogue for B&S Fluorescent Dyes 2013bsgroup
 
Nitration as per M.pharm syllabus of PCI
Nitration as per M.pharm syllabus of PCINitration as per M.pharm syllabus of PCI
Nitration as per M.pharm syllabus of PCIShikha Popali
 

What's hot (9)

Triphenylmethane and derivatives
Triphenylmethane and derivativesTriphenylmethane and derivatives
Triphenylmethane and derivatives
 
DƯỢC LÝ HỌC LÂM SÀNG NHI KHOA
DƯỢC LÝ HỌC LÂM SÀNG NHI KHOADƯỢC LÝ HỌC LÂM SÀNG NHI KHOA
DƯỢC LÝ HỌC LÂM SÀNG NHI KHOA
 
DƯỢC LÝ HỌC LÂM SÀNG NHI KHOA
DƯỢC LÝ HỌC LÂM SÀNG NHI KHOADƯỢC LÝ HỌC LÂM SÀNG NHI KHOA
DƯỢC LÝ HỌC LÂM SÀNG NHI KHOA
 
M3MP=MMP TDS
M3MP=MMP TDSM3MP=MMP TDS
M3MP=MMP TDS
 
B&S Group Fluorescent Dyes
B&S Group Fluorescent DyesB&S Group Fluorescent Dyes
B&S Group Fluorescent Dyes
 
Catalogue for B&S Fluorescent Dyes 2013
Catalogue for B&S Fluorescent Dyes 2013Catalogue for B&S Fluorescent Dyes 2013
Catalogue for B&S Fluorescent Dyes 2013
 
Yuanyue
YuanyueYuanyue
Yuanyue
 
Why we need and use LCMS
Why we need and  use LCMSWhy we need and  use LCMS
Why we need and use LCMS
 
Nitration as per M.pharm syllabus of PCI
Nitration as per M.pharm syllabus of PCINitration as per M.pharm syllabus of PCI
Nitration as per M.pharm syllabus of PCI
 

Similar to Drug discovery algorithm identifies REL1 inhibitors

Lab talk 180909 radioligand assay to validate in silico predicted rel1 inhib...
Lab talk 180909 radioligand assay to validate in silico predicted  rel1 inhib...Lab talk 180909 radioligand assay to validate in silico predicted  rel1 inhib...
Lab talk 180909 radioligand assay to validate in silico predicted rel1 inhib...Laurence Dawkins-Hall
 
Lab talk 060809 radioligand assay to validate in slico predicted rel inhibito...
Lab talk 060809 radioligand assay to validate in slico predicted rel inhibito...Lab talk 060809 radioligand assay to validate in slico predicted rel inhibito...
Lab talk 060809 radioligand assay to validate in slico predicted rel inhibito...Laurence Dawkins-Hall
 
Lab talk 201109 radioligand assay for validating in slico predicted rel1 anta...
Lab talk 201109 radioligand assay for validating in slico predicted rel1 anta...Lab talk 201109 radioligand assay for validating in slico predicted rel1 anta...
Lab talk 201109 radioligand assay for validating in slico predicted rel1 anta...Laurence Dawkins-Hall
 
M. Obayed Ullah_Group Meeting.pptx
M. Obayed Ullah_Group Meeting.pptxM. Obayed Ullah_Group Meeting.pptx
M. Obayed Ullah_Group Meeting.pptxMedicare24BD
 
Lab talk 020710 comparing bac r_rel 1 with e coli rrel 1 for use in fret assay
Lab talk 020710 comparing bac r_rel 1 with e coli rrel 1 for use in fret assayLab talk 020710 comparing bac r_rel 1 with e coli rrel 1 for use in fret assay
Lab talk 020710 comparing bac r_rel 1 with e coli rrel 1 for use in fret assayLaurence Dawkins-Hall
 
Biophysical studies of Thiopurine S-methyltransferase (TPMT) variants
Biophysical studies of Thiopurine S-methyltransferase  (TPMT) variantsBiophysical studies of Thiopurine S-methyltransferase  (TPMT) variants
Biophysical studies of Thiopurine S-methyltransferase (TPMT) variantsPaolo Dametto
 
Labtalk 151010 optimising fret assay_ligation buffer_[atp]_fluorophores
Labtalk 151010 optimising fret assay_ligation buffer_[atp]_fluorophoresLabtalk 151010 optimising fret assay_ligation buffer_[atp]_fluorophores
Labtalk 151010 optimising fret assay_ligation buffer_[atp]_fluorophoresLaurence Dawkins-Hall
 
Lab talk 020410 inducing rel 1 to set up ht fret assay_progress
Lab talk 020410 inducing rel 1 to set up ht fret assay_progressLab talk 020410 inducing rel 1 to set up ht fret assay_progress
Lab talk 020410 inducing rel 1 to set up ht fret assay_progressLaurence Dawkins-Hall
 
Molar extinction coefficient
Molar extinction coefficientMolar extinction coefficient
Molar extinction coefficientDhruv Sharma
 

Similar to Drug discovery algorithm identifies REL1 inhibitors (12)

Lab talk 180909 radioligand assay to validate in silico predicted rel1 inhib...
Lab talk 180909 radioligand assay to validate in silico predicted  rel1 inhib...Lab talk 180909 radioligand assay to validate in silico predicted  rel1 inhib...
Lab talk 180909 radioligand assay to validate in silico predicted rel1 inhib...
 
Lab talk 060809 radioligand assay to validate in slico predicted rel inhibito...
Lab talk 060809 radioligand assay to validate in slico predicted rel inhibito...Lab talk 060809 radioligand assay to validate in slico predicted rel inhibito...
Lab talk 060809 radioligand assay to validate in slico predicted rel inhibito...
 
Lab talk 201109 radioligand assay for validating in slico predicted rel1 anta...
Lab talk 201109 radioligand assay for validating in slico predicted rel1 anta...Lab talk 201109 radioligand assay for validating in slico predicted rel1 anta...
Lab talk 201109 radioligand assay for validating in slico predicted rel1 anta...
 
M. Obayed Ullah_Group Meeting.pptx
M. Obayed Ullah_Group Meeting.pptxM. Obayed Ullah_Group Meeting.pptx
M. Obayed Ullah_Group Meeting.pptx
 
Lab talk 020710 comparing bac r_rel 1 with e coli rrel 1 for use in fret assay
Lab talk 020710 comparing bac r_rel 1 with e coli rrel 1 for use in fret assayLab talk 020710 comparing bac r_rel 1 with e coli rrel 1 for use in fret assay
Lab talk 020710 comparing bac r_rel 1 with e coli rrel 1 for use in fret assay
 
Biophysical studies of Thiopurine S-methyltransferase (TPMT) variants
Biophysical studies of Thiopurine S-methyltransferase  (TPMT) variantsBiophysical studies of Thiopurine S-methyltransferase  (TPMT) variants
Biophysical studies of Thiopurine S-methyltransferase (TPMT) variants
 
Labtalk 151010 optimising fret assay_ligation buffer_[atp]_fluorophores
Labtalk 151010 optimising fret assay_ligation buffer_[atp]_fluorophoresLabtalk 151010 optimising fret assay_ligation buffer_[atp]_fluorophores
Labtalk 151010 optimising fret assay_ligation buffer_[atp]_fluorophores
 
MECC 2016 Poster
MECC 2016 PosterMECC 2016 Poster
MECC 2016 Poster
 
Drug screening
Drug screeningDrug screening
Drug screening
 
poster template 2015 4501
poster template 2015 4501poster template 2015 4501
poster template 2015 4501
 
Lab talk 020410 inducing rel 1 to set up ht fret assay_progress
Lab talk 020410 inducing rel 1 to set up ht fret assay_progressLab talk 020410 inducing rel 1 to set up ht fret assay_progress
Lab talk 020410 inducing rel 1 to set up ht fret assay_progress
 
Molar extinction coefficient
Molar extinction coefficientMolar extinction coefficient
Molar extinction coefficient
 

More from Laurence Dawkins-Hall

An evaluation of methods used to sequence pGEM template within core facilitie...
An evaluation of methods used to sequence pGEM template within core facilitie...An evaluation of methods used to sequence pGEM template within core facilitie...
An evaluation of methods used to sequence pGEM template within core facilitie...Laurence Dawkins-Hall
 
06 isafg p77 genome wide expression consequences of a disease resistance qtl ...
06 isafg p77 genome wide expression consequences of a disease resistance qtl ...06 isafg p77 genome wide expression consequences of a disease resistance qtl ...
06 isafg p77 genome wide expression consequences of a disease resistance qtl ...Laurence Dawkins-Hall
 
Genomic approaches to trypanosome resistance
Genomic approaches to trypanosome resistanceGenomic approaches to trypanosome resistance
Genomic approaches to trypanosome resistanceLaurence Dawkins-Hall
 
Genome responses of trypanosome infected cattle
Genome responses of trypanosome infected cattleGenome responses of trypanosome infected cattle
Genome responses of trypanosome infected cattleLaurence Dawkins-Hall
 
Systemic analysis of data combined from genetic qtl's and gene expression dat...
Systemic analysis of data combined from genetic qtl's and gene expression dat...Systemic analysis of data combined from genetic qtl's and gene expression dat...
Systemic analysis of data combined from genetic qtl's and gene expression dat...Laurence Dawkins-Hall
 
A systematic, data driven approach to the combined analysis of microarray and...
A systematic, data driven approach to the combined analysis of microarray and...A systematic, data driven approach to the combined analysis of microarray and...
A systematic, data driven approach to the combined analysis of microarray and...Laurence Dawkins-Hall
 
Labtalk 101210 optimising fret assay_den_optimising r_rel 1 production_heat s...
Labtalk 101210 optimising fret assay_den_optimising r_rel 1 production_heat s...Labtalk 101210 optimising fret assay_den_optimising r_rel 1 production_heat s...
Labtalk 101210 optimising fret assay_den_optimising r_rel 1 production_heat s...Laurence Dawkins-Hall
 
Lab talk 070510 inducing r_rel1 for establishing fret assay_ic50 studies with...
Lab talk 070510 inducing r_rel1 for establishing fret assay_ic50 studies with...Lab talk 070510 inducing r_rel1 for establishing fret assay_ic50 studies with...
Lab talk 070510 inducing r_rel1 for establishing fret assay_ic50 studies with...Laurence Dawkins-Hall
 
Genomic analysis of a hypertensive qtl on rat chr 1
Genomic analysis of a hypertensive qtl on rat chr 1Genomic analysis of a hypertensive qtl on rat chr 1
Genomic analysis of a hypertensive qtl on rat chr 1Laurence Dawkins-Hall
 
RNA editing as a drug target in tryp assay dev woodshole 2011
RNA editing as a drug target in tryp assay dev woodshole 2011RNA editing as a drug target in tryp assay dev woodshole 2011
RNA editing as a drug target in tryp assay dev woodshole 2011Laurence Dawkins-Hall
 
RNA editing as a drug target in tryp assay dev woods_hole2_0411 acs v2
RNA editing as a drug target in tryp assay dev woods_hole2_0411 acs v2RNA editing as a drug target in tryp assay dev woods_hole2_0411 acs v2
RNA editing as a drug target in tryp assay dev woods_hole2_0411 acs v2Laurence Dawkins-Hall
 
RNA editing as a drug target in tryp. development of a high throughput sceeni...
RNA editing as a drug target in tryp. development of a high throughput sceeni...RNA editing as a drug target in tryp. development of a high throughput sceeni...
RNA editing as a drug target in tryp. development of a high throughput sceeni...Laurence Dawkins-Hall
 
Rna editing as a drug target identification of inhibitors of rel 1 bsp 2010
Rna editing as a drug target identification of inhibitors of rel 1 bsp 2010Rna editing as a drug target identification of inhibitors of rel 1 bsp 2010
Rna editing as a drug target identification of inhibitors of rel 1 bsp 2010Laurence Dawkins-Hall
 
Rna editing as a drug target identification of inhibitors of rel 1 bsp 210
Rna editing as a drug target identification of inhibitors of rel 1 bsp 210Rna editing as a drug target identification of inhibitors of rel 1 bsp 210
Rna editing as a drug target identification of inhibitors of rel 1 bsp 210Laurence Dawkins-Hall
 
RNA editing as a drug target in tryp. development of a high throughput fluore...
RNA editing as a drug target in tryp. development of a high throughput fluore...RNA editing as a drug target in tryp. development of a high throughput fluore...
RNA editing as a drug target in tryp. development of a high throughput fluore...Laurence Dawkins-Hall
 
RNA editing as a drug target development of a high through put fluorescent as...
RNA editing as a drug target development of a high through put fluorescent as...RNA editing as a drug target development of a high through put fluorescent as...
RNA editing as a drug target development of a high through put fluorescent as...Laurence Dawkins-Hall
 
Abstract bookfinal-3 bsp 2012 glasgow
Abstract bookfinal-3 bsp 2012 glasgowAbstract bookfinal-3 bsp 2012 glasgow
Abstract bookfinal-3 bsp 2012 glasgowLaurence Dawkins-Hall
 

More from Laurence Dawkins-Hall (18)

DSRG report 2001
DSRG report 2001DSRG report 2001
DSRG report 2001
 
An evaluation of methods used to sequence pGEM template within core facilitie...
An evaluation of methods used to sequence pGEM template within core facilitie...An evaluation of methods used to sequence pGEM template within core facilitie...
An evaluation of methods used to sequence pGEM template within core facilitie...
 
06 isafg p77 genome wide expression consequences of a disease resistance qtl ...
06 isafg p77 genome wide expression consequences of a disease resistance qtl ...06 isafg p77 genome wide expression consequences of a disease resistance qtl ...
06 isafg p77 genome wide expression consequences of a disease resistance qtl ...
 
Genomic approaches to trypanosome resistance
Genomic approaches to trypanosome resistanceGenomic approaches to trypanosome resistance
Genomic approaches to trypanosome resistance
 
Genome responses of trypanosome infected cattle
Genome responses of trypanosome infected cattleGenome responses of trypanosome infected cattle
Genome responses of trypanosome infected cattle
 
Systemic analysis of data combined from genetic qtl's and gene expression dat...
Systemic analysis of data combined from genetic qtl's and gene expression dat...Systemic analysis of data combined from genetic qtl's and gene expression dat...
Systemic analysis of data combined from genetic qtl's and gene expression dat...
 
A systematic, data driven approach to the combined analysis of microarray and...
A systematic, data driven approach to the combined analysis of microarray and...A systematic, data driven approach to the combined analysis of microarray and...
A systematic, data driven approach to the combined analysis of microarray and...
 
Labtalk 101210 optimising fret assay_den_optimising r_rel 1 production_heat s...
Labtalk 101210 optimising fret assay_den_optimising r_rel 1 production_heat s...Labtalk 101210 optimising fret assay_den_optimising r_rel 1 production_heat s...
Labtalk 101210 optimising fret assay_den_optimising r_rel 1 production_heat s...
 
Lab talk 070510 inducing r_rel1 for establishing fret assay_ic50 studies with...
Lab talk 070510 inducing r_rel1 for establishing fret assay_ic50 studies with...Lab talk 070510 inducing r_rel1 for establishing fret assay_ic50 studies with...
Lab talk 070510 inducing r_rel1 for establishing fret assay_ic50 studies with...
 
Genomic analysis of a hypertensive qtl on rat chr 1
Genomic analysis of a hypertensive qtl on rat chr 1Genomic analysis of a hypertensive qtl on rat chr 1
Genomic analysis of a hypertensive qtl on rat chr 1
 
RNA editing as a drug target in tryp assay dev woodshole 2011
RNA editing as a drug target in tryp assay dev woodshole 2011RNA editing as a drug target in tryp assay dev woodshole 2011
RNA editing as a drug target in tryp assay dev woodshole 2011
 
RNA editing as a drug target in tryp assay dev woods_hole2_0411 acs v2
RNA editing as a drug target in tryp assay dev woods_hole2_0411 acs v2RNA editing as a drug target in tryp assay dev woods_hole2_0411 acs v2
RNA editing as a drug target in tryp assay dev woods_hole2_0411 acs v2
 
RNA editing as a drug target in tryp. development of a high throughput sceeni...
RNA editing as a drug target in tryp. development of a high throughput sceeni...RNA editing as a drug target in tryp. development of a high throughput sceeni...
RNA editing as a drug target in tryp. development of a high throughput sceeni...
 
Rna editing as a drug target identification of inhibitors of rel 1 bsp 2010
Rna editing as a drug target identification of inhibitors of rel 1 bsp 2010Rna editing as a drug target identification of inhibitors of rel 1 bsp 2010
Rna editing as a drug target identification of inhibitors of rel 1 bsp 2010
 
Rna editing as a drug target identification of inhibitors of rel 1 bsp 210
Rna editing as a drug target identification of inhibitors of rel 1 bsp 210Rna editing as a drug target identification of inhibitors of rel 1 bsp 210
Rna editing as a drug target identification of inhibitors of rel 1 bsp 210
 
RNA editing as a drug target in tryp. development of a high throughput fluore...
RNA editing as a drug target in tryp. development of a high throughput fluore...RNA editing as a drug target in tryp. development of a high throughput fluore...
RNA editing as a drug target in tryp. development of a high throughput fluore...
 
RNA editing as a drug target development of a high through put fluorescent as...
RNA editing as a drug target development of a high through put fluorescent as...RNA editing as a drug target development of a high through put fluorescent as...
RNA editing as a drug target development of a high through put fluorescent as...
 
Abstract bookfinal-3 bsp 2012 glasgow
Abstract bookfinal-3 bsp 2012 glasgowAbstract bookfinal-3 bsp 2012 glasgow
Abstract bookfinal-3 bsp 2012 glasgow
 

Recently uploaded

Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.aasikanpl
 
Physiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptxPhysiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptxAArockiyaNisha
 
GFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptxGFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptxAleenaTreesaSaji
 
Nanoparticles synthesis and characterization​ ​
Nanoparticles synthesis and characterization​  ​Nanoparticles synthesis and characterization​  ​
Nanoparticles synthesis and characterization​ ​kaibalyasahoo82800
 
Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...Nistarini College, Purulia (W.B) India
 
Orientation, design and principles of polyhouse
Orientation, design and principles of polyhouseOrientation, design and principles of polyhouse
Orientation, design and principles of polyhousejana861314
 
Natural Polymer Based Nanomaterials
Natural Polymer Based NanomaterialsNatural Polymer Based Nanomaterials
Natural Polymer Based NanomaterialsAArockiyaNisha
 
Isotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on IoIsotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on IoSérgio Sacani
 
Boyles law module in the grade 10 science
Boyles law module in the grade 10 scienceBoyles law module in the grade 10 science
Boyles law module in the grade 10 sciencefloriejanemacaya1
 
Artificial Intelligence In Microbiology by Dr. Prince C P
Artificial Intelligence In Microbiology by Dr. Prince C PArtificial Intelligence In Microbiology by Dr. Prince C P
Artificial Intelligence In Microbiology by Dr. Prince C PPRINCE C P
 
Luciferase in rDNA technology (biotechnology).pptx
Luciferase in rDNA technology (biotechnology).pptxLuciferase in rDNA technology (biotechnology).pptx
Luciferase in rDNA technology (biotechnology).pptxAleenaTreesaSaji
 
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...Sérgio Sacani
 
Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?Patrick Diehl
 
A relative description on Sonoporation.pdf
A relative description on Sonoporation.pdfA relative description on Sonoporation.pdf
A relative description on Sonoporation.pdfnehabiju2046
 
Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)PraveenaKalaiselvan1
 
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.aasikanpl
 
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCESTERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCEPRINCE C P
 
Stunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCR
Stunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCRStunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCR
Stunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCRDelhi Call girls
 
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |aasikanpl
 
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...anilsa9823
 

Recently uploaded (20)

Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
 
Physiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptxPhysiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptx
 
GFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptxGFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptx
 
Nanoparticles synthesis and characterization​ ​
Nanoparticles synthesis and characterization​  ​Nanoparticles synthesis and characterization​  ​
Nanoparticles synthesis and characterization​ ​
 
Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...
 
Orientation, design and principles of polyhouse
Orientation, design and principles of polyhouseOrientation, design and principles of polyhouse
Orientation, design and principles of polyhouse
 
Natural Polymer Based Nanomaterials
Natural Polymer Based NanomaterialsNatural Polymer Based Nanomaterials
Natural Polymer Based Nanomaterials
 
Isotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on IoIsotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on Io
 
Boyles law module in the grade 10 science
Boyles law module in the grade 10 scienceBoyles law module in the grade 10 science
Boyles law module in the grade 10 science
 
Artificial Intelligence In Microbiology by Dr. Prince C P
Artificial Intelligence In Microbiology by Dr. Prince C PArtificial Intelligence In Microbiology by Dr. Prince C P
Artificial Intelligence In Microbiology by Dr. Prince C P
 
Luciferase in rDNA technology (biotechnology).pptx
Luciferase in rDNA technology (biotechnology).pptxLuciferase in rDNA technology (biotechnology).pptx
Luciferase in rDNA technology (biotechnology).pptx
 
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
 
Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?
 
A relative description on Sonoporation.pdf
A relative description on Sonoporation.pdfA relative description on Sonoporation.pdf
A relative description on Sonoporation.pdf
 
Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)
 
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
 
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCESTERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
 
Stunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCR
Stunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCRStunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCR
Stunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCR
 
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |
 
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
 

Drug discovery algorithm identifies REL1 inhibitors

  • 1. CompoundCompound ClassClass SetSet # substances# substances Drug discovery algorithmDrug discovery algorithm 1. NCI #1 #1 16 Compounds screened with ‘Auto dock 4’ Ranked Verified with so-called ‘relaxed complex scheme’ 2. FDA #2 1 in house (sigma) 11 more predicted but financially prohibitive 1 pending (Dec 2009) 3. NCI #2 #3 8 Identified using a fragment based approach:  Initially docked small fragments into REL 1  Identified favourable fragments  Linked together and several databases screened 4. Hit 2 lead #3 15 5. Sigma #3 2 Identify compounds that bind to ATP binding pocket of REL 1, viz. :Identify compounds that bind to ATP binding pocket of REL 1, viz. : 1 Strong lead !1 Strong lead ! 3 Strong leads !3 Strong leads ! 2 Nominal_100uM2 Nominal_100uM Also,Tetracycline needs to be evaluatedAlso,Tetracycline needs to be evaluated
  • 2. CompoundCompound TypeType CompoundCompound 1010µµMM 100100µMµM TitratedTitrated N=N= ICIC5050 RangeRange CommentsComments NCI BatchNCI Batch #2#2 # 45609 ! 95 % (78%) (88%) 33 3-1uM  Discrepancy between assays above predicted IC50 range  Repeat ? Discrepancy between assays Repeated ! (#0036) # 162535 !!# 162535 !! 85_90 % (85%) (~98%)* (90 %) (>99.9%)* >3>3 (+2)(+2) ~1uM (N=1) ~3-1uM (N=3) # 1698 ! 80 % (50%) (90%) 33 (+2)(+2) 10uM- 3uM (N=2) 3-1uM (N=1) NCI BatchNCI Batch #1#1 # 117079 30_80% >99% (~80 %) (~50-70%) >3>3 100uM- 30uM (N=4)  30uM (N=1) Discrepancy between assays above IC50 range  Furthermore, IC50’s differ between assays  Repeat ? # 125908 20_70% ~95 % (~50-70%) >3>3 100uM- 30uM (N=3)  ~30uM (N=1) # 45201 NA ~70% Yet to do !!Yet to do !! Sigma rareSigma rare LibraryLibrary MordantMordant Black !!Black !! (~98%)* (~99.8%)* >3>3 ~1uM Completed  Values derive from titrations’  Identified using fragment based algorithm  Identified using Auto Dock 4 relaxed complex scheme Assay #0036 is an attempt to clarify IC50’s for # 1698 & #162535 Regarding # 45609 IC50’s concur but values differ above this threshold Regarding #117079 & #125908 some assays have different IC50’s Furthermore, those with similar values differ above IC50 titrant * Values derived from 0.25ul undiluted prep #1
  • 3. 34B MBMB #162535#162535 # 45609# 45609 # 1698# 1698 1uM1uM >/=1uM>/=1uM 3-1uM3-1uM >3uM>3uM
  • 4. % (Putative) Inhibition of REL 1 Ligation (Adenylation) by Mordant Black (solute) relative to DMSO (solvent)_# Mordant Black Molarity Titration 100uM 100uM 30uM 30uM 10uM 10uM DMSO DMSO 3uM 3uM 1uM 1uM 300nM 300nM 100nM 100nM 30nM 30nM 0 20 40 60 80 100 120 140 Prep #3_050203 Prep #1_080802 Mordant Black Molarity Titration: 100uM-30nM SpecificSignal/DMSO_% 3.4%3.4% 10%10% 23.7%23.7% 52%52% 81%81% <0.5%<0.5% 5%5% 26.5%26.5% 55.8%55.8% 75%75% 1ul Enzyme1ul Enzyme 0.25ul Enzyme0.25ul Enzyme Although both REL 1 BAC preps differ with regard to intrinsic activity both yield putative IC50’s approx to 1uM This concurs with prior assays100uM100uM 30nM30nM 50S50S-1-1 100S100S-1-1
  • 5. % (Putative) Inhibition of Ligation (Adenylation) by Mordant Black (solute) relative to DMSO (solvent)_# Mordant Black Molarity Titration 30uM 30uM 10uM 10uM 10uM 100uM 100uM 100uM 30uM 0 20 40 60 80 100 120 140 Prep #3_050203 Prep #1_080802 Prep #1_080802 Mordant Black Molarity Titration: 100uM-30nM SpecificSignal/DMSO_% # 0029A # 0033A 28,500,000 152,500,000 203,500,000 52% 56% 54% 1ul 50% REL 1 0.25ul 50% REL 1 1ul undiluted REL 1 17 HR17 HR 1 HR ! For assays depicted (N=3) IC50 consistently approximates to ~1uM Undiluted prep #1 displays massively greater signal than either glycerol diluted #1 or #3
  • 6. % (Putative) Inhibition of Ligation (Adenylation) by Mordant Black (solute) relative to DMSO (solvent)_# Mordant Black Molarity Titration DMSO DMSO 100uM 100uM 30uM 30uM 10uM 10uM 3uM 3uM 1uM 1uM 300nM 300nM 100nM 100nM 30nM 30nM 0 20 40 60 80 100 120 140 Prep #1_080802 Prep #3_050203 Molarity Titration: 100uM-30nM SpecificSignal/DMSO_% 24+/-5.6% 59+/-5.2% 24% 52% IC50 approximates to 1uM for N=5 Combining data from assays #0029_33_34 culminates in predicted IC50 of ~1uM (N=4) In terms of IC50 alone this is consistent with data from REL 1 prep #3 also derived from #0029
  • 7. % (Putative) Inhibition of Ligation (Adenylation) by #162535 (solute) relative to DMSO (solvent)_# 162535 Molarity Titration DMSO DMSO DMSO 3uM 3uM 3uM 1uM 1uM 1uM 0 20 40 60 80 100 120 140 160 180 # 0018A # 0033B # 0034B Molarity Titration: 100uM-30nM MeanSpecificsignal/DMSO_% DMSO 100uM 30uM 10uM 3uM 1uM 300nM 100nM 30nM # 162535 1ul Undiluted Prep #1_080802 0.25ul Undiluted Prep #1_0808020.5ul 50% Glycerol diluted prep 36% 67% 42% 90% 12% 48% 25,000,000 217,000,000 45,000,000 For N=3 predicted IC50 approximates to ~ 2uM For N=1 predicted IC50 ~1uM (1ul undiluted prep #1) Therefore repeated using 0.25ul undiluted prep #1 Thus, now N=4 for 0.25ul undiluted prep #1 Repeated !Repeated !
  • 8. Variable background was a confounding factor when it came to signal comparison for the different titrants Nevertheless, evident IC50 was approximately 1uM This concurs with assays #34 & #35
  • 9. % (Putative) Inhibition of Ligation (Adenylation) by #1698 (solute) relative to DMSO (solvent)_# 1698 Molarity Titration DMSO DMSO 100uM 100uM 30uM 30uM 10uM 10uM 3uM 3uM 1uM 1uM 300nM 300nM 100nM 100nM 30nM 30nM 0 20 40 60 80 100 120 # 0018B # 0035A MeanSpecificSignal/DMSO_% IC50 resides here # 1698 28, 000,000 190, 000,000 27% 53% 38% 61% For N=1 predicted IC50 approximates to 10uM For N=2 predicted IC50 lies somewhere between 10uM & 3uM #0035A = 0.25ul undiluted prep #1_080802 Therefore repeated using (similarly) 0.25ul undiluted prep #1 Thus, for 0.25ul undiluted prep #1, now N=4 ! Repeated !Repeated !
  • 10. 108, 000, 000 counts108, 000, 000 counts 153, 000, 000 counts153, 000, 000 counts
  • 11. % (Putative) Inhibition of Ligation (Adenylation) by #45609 (solute) relative to DMSO (solvent)_# 45609 Molarity Titration DMSO DMSO 100uM 100uM 30uM30uM 10uM 10uM 3uM 3uM 1uM 1uM 300nM 300nM 100nM 100nM 30nM 30nM 0 20 40 60 80 100 120 140 # 0035B # 0016B Molar Titration MeanSpecificSignal_%DMSO IC50 resides here 199,000,000 counts ! 10,000,000 counts ! 0.9% 1.6% 7.9% 36% 68% IC50 resides here 12% 16% 22% 38% 74% Thus, for N=3 predicted of IC50 ~3-1uM However, above this threshold, titrants for respective assays differ considerably with respect to putative inhibition  Assay #0016B = 0.5ul 50 % glycerol diluted prep  Assay #0035B = 0.25ul undiluted prep #1_080802 Repeat ??Repeat ??
  • 12. % (Putative) Inhibition of REL 1 Ligation (Adenylation) by #117079 (solute) relative to DMSO (solvent)_# 117079 Molarity Titration DMSO DMSO 100uM 100uM 30uM 30uM 10uM 10uM 3uM 3uM 1uM 1uM 300nM 300nM 100nM 100nM 30nM 30nM 0.0 20.0 40.0 60.0 80.0 100.0 120.0 140.0 BAC Prep #3_050203 BAC Prep #1_080802 #117079 Molarity Titration: 100uM-30nM SpecificSignal/DMSO_% 18.6%18.6% 54%54% 23.4%23.4% 75.6%75.6% 1ul Enzyme1ul Enzyme 0.25ul Enzyme0.25ul Enzyme Predicted IC50 Prep #3 ~30uM Predicted IC50 for prep #100uM-30uM The latter concurs with previous assays50S50S-1-1 100S100S-1-1
  • 13. IC50 resides somewhere between 100uM & 30uM In the main, this concurs with previous assays, i.e.:  #0011 & #0012  #0029B_Prep #1_080802 However, predicted IC50 for #29B_prep #3 approx. to 30uM rather than 100uM To illustrate discrepancies further:  Putative inhibition @100uM for assays #0011 & #0012 >99%  For assay #0029B ~ 80%  For assay #0032A/B ~ 50 -70% # 117079 Molarity Titration: 1mM-1uM# 117079 Molarity Titration: 1mM-1uM 10S10S-1-1 10-20S10-20S-1-132A 32B5S5S-1-1 10S10S-1-1 1ul Prep #31ul Prep #3
  • 14. % (Putative) Inhibition of REL 1 Ligation (Adenylation) by #125908 (solute) relative to DMSO (solvent): # 125908 Molarity Titration. Assay #0031A 1mM 1mM DMSO DMSO 300uM 100uM 100uM 30uM 30uM 10uM 10uM 3uM 3uM 1uM 1uM 0 20 40 60 80 100 120 140 # 31A_1 # 31A_2 Molarity Titration: 1mM-1uM SpecificSignal/DMSO_% 32.5% 77.7% 17.4% 48.4% 86.4% IC50 resides here IC50 resides here
  • 15. % (Putative) Inhibition of REL 1 Ligation (Adenylation) by #125908 (solute) relative to DMSO (solvent): # 125908 Molarity Titration. Assay #0031B DMSO DMSO 1mM1mM 300uM 300uM 100uM 100uM 30uM 30uM 10uM 10uM 3uM 3uM 1uM 1uM 0 20 40 60 80 100 120 140 # 31B_1 # 31B_2 Molarity Titration: 1mM-1uM SpecificSignal/DMSO_% 17.4% 35.5% 60.9% 13.4% 30.2% 51.4% IC50 resides here IC50 resides here Predicted IC50 ~30uM: N=1 Predicted IC50 100uM-30uM: N=3 The latter concurs with previous assays
  • 16. % (Putative) Inhibition of REL 1 Ligation (Adenylation) by #117079 (solute) relative to DMSO (solvent): #117079 Molarity Titration. Assay #0032A/B DMSO 1m M 300uM 100uM 30uM 10uM 3uM 1uM 0 20 40 60 80 100 120 N = 3 Molarity Titration #117079: 1mM - 1uM MeanSpecificSignal/DMSO_% DMSO 1mM 300uM 100uM 30uM 10uM 3uM 1uM Plan of action:Plan of action: 1. Either combine this data with #0029B_prep #1 (N=4) 2. Or repeat assay 0.25ul undiluted prep #1_080809
  • 17. =10=10µMµM =100=100µMµM Low S:N precluded quantitation ! This was even true of depicted assay #0026, wherein cassette left for 6 days ! BAC 1 prep with low intrinsic activity (also common to H2L compounds)
  • 18.  Green = 1ul 50% Prep #3_050203 + 0.1% Triton X-100  Black = 1ul undiluted prep #1_080802  Blue = 1ul undiluted prep #1_080802  Green = 0.25ul undiluted prep #1_080802 200S200S-1-1 1000S1000S-1-133A 33B100S100S-1-1 1000S1000S-1-1
  • 19. Loss of Specific Signal (DMSO) with Freeze thawing: REL1 'prep #3_050203' vs 'Prep #1_080802' #0031 #0032 #0027 #0027 #0029 #0029 #0034 #0035 #0036 0.00E+00 5.00E+07 1.00E+08 1.50E+08 2.00E+08 2.50E+08 DMSO_#1_0.25ul DMSO_#3_0.25_1ul Assays SpecificSignal #0027 #0029 #0031 #0032 #0034 #0035 #0036 0.25ul undiluted Prep #3_050203 0.25ul Prep #1_080802 1ul 50 % Prep #3_050203
  • 20. SummarySummary 1. Mordant black has evident IC50 approximating to 1uM (N=5): Best lead !! 2. Regarding #45609, assays alight on IC50 approximating to 3-1uM (N=3) but differ with respect to putative titrant inhibition above that threshold; Repeat ? 3. With reference to #162535 & #1698, discrepancies evident between assay predicted IC50 values and for #1698 in particular N<3 for alternative values; There fore repeated (#0036) 4. Regarding #117079 & #125908, some assays display putative different IC50’s but an N>/=3 exists for one value 5. However, titrant values above the predicted IC50 thresholds also differ: Repeat ? In general, same enzyme batches concur more often and undiluted prep #1_080802 has yielded highest signal to noise Thus, in general and N>/= 3 derived from this REL 1 batch would constitute the ideal Future WorkFuture Work 1. Quantify #0036 2. Repeat other assays described to nullify IC50 and preferably titrant differences in general, with a bias towards N>/= 3 from the same enzyme batch 3. Submit putative inhibitory values to Graph Pad Prism© to compute exact IC50s’ 4. Complete titrations for #45201